Angiotensin Converting Enzyme Inhibition Early after Heart Transplantation

BACKGROUND: Cardiac allograft vasculopathy (CAV) remains a leading cause of mortality after heart transplantation (HT). Angiotensin converting enzyme inhibitors (ACEIs) may retard the development of CAV, but have not been well studied after HT. OBJECTIVES: We tested the safety and efficacy of the AC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Coll Cardiol
Main Authors: Fearon, William F., Okada, Kozo, Kobashigawa, Jon A., Kobayashi, Yuhei, Luikart, Helen, Sana, Sean, Daun, Tiffany, Chmura, Steven A., Sinha, Seema, Cohen, Garett, Honda, Yasuhiro, Pham, Michael, Lewis, David B., Bernstein, Daniel, Yeung, Alan C., Valantine, Hannah A., Khush, Kiran
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546225/
https://ncbi.nlm.nih.gov/pubmed/28595700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2017.03.598
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados